The anxious bipolar phenotype: clinical complexity and treatment response.

Int J Bipolar Disord · 2026 · PMC13038839 · PMID 41741804

Europe PMC DOI

hedged sentence

0.0470

closest p · 0.9× alpha

0.0470

boldest claim

The sentences

showed a trendp = 0.047actually significant

47.8%, p = 0.005) and showed a trend towards lower valproic acid use (21.7% vs. 29.6%, p = 0.047), but more likely to receive antidepressants (53.8% vs. 39.5%, p < 0.001), benzodiazepines (39.9% vs. 26.6%, p < 0.001), and gabapentinoids (8.5% vs. 4.5%, p < 0.001).

also in 28,865 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.